Join
Live feed
·
INSIDERFilingvia Quantisnow
Global Blood Therapeutics Inc. logo

SEC Form 4: Habibizad Nazila sold $314,315 worth of shares (4,678 units at $67.19), decreasing direct ownership by 34% to 8,918 units

ByQuantisnow·Wall Street's wire, on your screen.
GBT· Global Blood Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GBT (Global Blood Therapeutics Inc.) and more on Quantisnow.